S F Moss
Overview
Explore the profile of S F Moss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1802
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Safety, tolerability and efficacy of a novel self-use biodegradable device for management of obesity
Shirin H, Richter V, Matalon S, Abramowich D, Maliar A, Shachar E, et al.
Obes Sci Pract
. 2019 Aug;
5(4):376-382.
PMID: 31452922
Objective: Obesity is a major public health issue with significant impact on quality of life, morbidity and mortality rates. It is estimated that if the current trends continue, 18% of...
2.
Siddique O, Moss S
Aliment Pharmacol Ther
. 2018 Jun;
48(1):95-96.
PMID: 29882987
No abstract available.
3.
Wen S, So Y, Singh K, Slingerland J, Resnick M, Zhang S, et al.
Oncogene
. 2011 Aug;
31(14):1771-80.
PMID: 21841827
The cyclin-dependent kinase (CDK) inhibitor p27 has an important role in cell cycle regulation. Reduced expression of p27 is commonly associated with poor prognosis in many malignancies, including gastric cancer....
4.
Modlin I, Hunt R, Malfertheiner P, Moayyedi P, Quigley E, Tytgat G, et al.
Digestion
. 2009 Jun;
80(2):74-88.
PMID: 19546560
Background/aims: Although considerable information exists regarding gastroesophageal reflux disease with erosions, much less is known of non-erosive reflux disease (NERD), the dominant form of reflux disease in the developed world....
5.
McGowan C, Saha S, Chu G, Resnick M, Moss S
South Med J
. 2009 Apr;
102(5):493-7.
PMID: 19373153
Background: Sodium polystyrene sulfonate (SPS, Kayexalate) has been implicated in the development of intestinal necrosis. Sorbitol, added as a cathartic agent, may be primarily responsible. Previous studies have documented bowel...
6.
Pellish R, Nasir A, Ramratnam B, Moss S
Aliment Pharmacol Ther
. 2008 Feb;
27(9):715-23.
PMID: 18248657
Background: A new technique of gene regulation, termed RNA interference, has emerged recently. RNA interference utilizes short double-stranded RNA to inhibit selectively gene expression of complementary RNA nucleotide sequences after...
7.
Resnick M, Sabo E, Meitner P, Kim S, Cho Y, Kim H, et al.
Gut
. 2006 Apr;
55(12):1717-24.
PMID: 16641130
Objective: The transcriptional profile of gastric epithelial cell lines cocultured with Helicobacter pylori and the global gene expression of whole gastric mucosa has been described previously. We aimed to overcome...
8.
Malfertheiner P, Fass R, Quigley E, Modlin I, Malagelada J, Moss S, et al.
Aliment Pharmacol Ther
. 2006 Mar;
23(6):683-90.
PMID: 16556170
To commemorate Edkins' discovery of gastrin in 1905, we review a century of progress in the physiology and pathobiology of gastrin and acid secretion especially as it pertains to clinical...
9.
Levine A, Shevah O, Shabat-Sehayek V, Aeed H, Boaz M, Moss S, et al.
Aliment Pharmacol Ther
. 2004 Jul;
20(1):117-22.
PMID: 15225178
Background: The need to withhold acid suppression therapy while awaiting urea breath test results is a common clinical problem in symptomatic patients. It is unclear at present if the dose...
10.
Eguchi H, Carpentier S, Kim S, Moss S
Gut
. 2004 May;
53(6):797-804.
PMID: 15138205
Background: Helicobacter pylori infection increases the risk of gastric cancer but the molecular mechanisms responsible are not well understood. Gastric cells chronically exposed to H pylori in vitro develop resistance...